All Clinical Trials
Enrolling Now
ADAPTIVE Eczema Trial
We are enrolling adults with moderate-to-severe eczema (atopic dermatitis) for a clinical trial evaluating an investigational, injectable treatment called IMG-007. Participation is at no cost to you.
See If You QualifyWho Can Participate
Eligibility
- Ages 18–70Men and women between 18 and 70 years old, inclusive.
- Eczema Diagnosed for at Least 1 YearYou must have had a confirmed diagnosis of atopic dermatitis for at least one year.
- Moderate to Severe EczemaEczema affecting more than 10% of your body (roughly 10 or more palm prints), with an itch intensity of at least 4 on a 0–10 scale.
- Prior Topical Treatment HistoryPrescription topical treatments have not adequately controlled your symptoms, or you have been advised not to use them.
What's Involved
- ✓ Up to 16 MonthsTwo 24-week treatment periods, for a total study duration of up to 16 months.
- ✓ Up to 20 Clinic VisitsEach visit is approximately 2.5 to 4 hours. Visits take place at our Seattle-area research clinic.
- ✓ Investigational Injectable TreatmentIMG-007 is administered as a subcutaneous (under-the-skin) injection. Some participants may receive a placebo during the first period; all active participants receive treatment in the second period.
- ✓ No Cost to YouAll study-related care and medication are provided at no cost. No insurance is necessary.
- ✓ Strictly ConfidentialYour information is kept confidential and is not shared without your permission, except as required by law.
Pre-Screening
See If You Pre-Qualify
Answer a few questions about your condition. You may stop at any time and don't need to answer anything that makes you uncomfortable. We'll review your information and contact you shortly.
Thank You
We've received your information and will review it shortly. If you'd like to reach us sooner, call us directly.
Have questions before applying?
Email our research team — we'll walk you through eligibility before any commitment is made.